Quarterly report pursuant to Section 13 or 15(d)

RESTRUCTURING CHARGES (Tables)

v3.23.3
RESTRUCTURING CHARGES (Tables)
9 Months Ended
Sep. 30, 2023
RESTRUCTURING CHARGES.  
Schedule of employee severance, benefits and related costs

During the nine months ended September 30, 2023 and 2022, the Company recorded the following activity related to the Initiative in accrued expenses and other current liabilities on the balance sheet (in thousands):

Nine Months Ended September 30, 

2023

2022

Accrued expenses, beginning of period

$

1,095

$

Restructuring charges

6,610

12,782

Cash payments

(2,317)

(1,478)

Stock-based compensation

(7,313)

Inventory write-off

(2,484)

(3,085)

Accrued expenses, end of period

$

2,904

$

906

Schedule of restructuring and related costs

During the three and nine months ended September 30, 2023, the Company recorded restructuring charges of $0.1 million and $6.6 million, respectively, related to employee severance, benefits and related costs, inventory write-offs, royalty expenses associated with discontinued product offerings, and facility consolidations which were expensed as follows (in thousands):

Three Months Ended September 30, 

Nine Months Ended September 30, 

2023

2022

2023

2022

Cost of sales

$

16

$

3,085

$

3,221

$

3,126

Research and development

187

3,085

8,117

Sales and marketing

(62)

68

667

General and administrative

 

1

 

 

236

 

489

Interest and other (expense) income, net

383

Total restructuring charges

$

142

$

3,085

$

6,610

$

12,782